|
시장보고서
상품코드
2019217
산업용 람노리피드 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)Industrial Rhamnolipid Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 산업용 람노리피드 시장은 2025년에 4억 6,780만 달러로 평가되었으며, CAGR 8.4%로 성장하여 2035년까지 9억 5,050만 달러에 달할 것으로 추정됩니다.
산업용 람노리피드는 초기에는 틈새시장인 바이오 유래 계면활성제로 등장했지만, 현재는 여러 산업 분야에서 필수적인 성분으로 발전하고 있습니다. 현재 에너지 생산, 산업용 세정, 농업, 환경 복원 등의 분야에서 공정 효율 향상, 재료 적합성 강화, 운영 신뢰성 확보 등 기능적 용도가 확대되고 있습니다. 산업 분야의 조달은 재생 가능하고, 독성이 낮고, 환경적으로 지속가능하며, 동시에 높은 성능을 발휘하는 원료를 점점 더 선호하고 있습니다. 생명공학, 발효 제어, 균주 최적화 및 후공정 처리의 발전으로 람노리피드의 성능은 산업 표준을 충족하는 수준으로 향상되었습니다. 배합 적합성, 생분해성, 낮은 환경 잔류성 등이 결합되어 특히 규제가 엄격하고 지속가능성 요구가 높은 지역에서 채택이 가속화되고 있으며, 기존 시장과 신흥 시장 모두에서 꾸준한 성장을 견인하고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035 |
| 시작 시점 시장 규모 | 4억 6,780만 달러 |
| 예측 규모 | 9억 5,050만 달러 |
| CAGR | 8.4% |
모노람노리피드 부문은 60.4%의 점유율을 차지하고 있으며, 2035년까지 CAGR 7.8%로 성장할 것으로 예상됩니다. 그 광범위한 사용은 우수한 계면활성, 용해성 및 제제와의 상용성에 기인합니다. 각 산업계에서는 계면 장력을 감소시키는 비용 효율적인 성능으로 인해 세정, 유전 화학, 환경 복원 등의 용도에 모노람노리파이드를 활용하고 있습니다. 다이람노리피드는 시장 규모는 작지만 우수한 유화 특성, 가혹한 조건에서의 안정성 및 장기적인 기능 내구성으로 인해 주목을 받고 있습니다.
액체 제제 부문은 2025년 70.6%의 점유율을 차지했으며, 2026년부터 2035년까지 CAGR 8.1%로 성장할 것으로 예측됩니다. 액체 람노리피드는 취급의 용이성, 즉각적인 용해성, 유전 작업, 산업용 세정, 환경 처리 등의 공정에 원활하게 통합할 수 있어 대규모 산업 응용 분야에서 선호되고 있습니다. 연속 가공에 대한 적합성, 정확한 투약, 유연한 제형 개발이 가능하다는 점이 산업 분야에서 인기를 더욱 높이고 있습니다.
북미 산업용 람노리피드 시장은 에너지 생산, 산업용 세정, 환경 보호 분야에서 바이오 유래 계면활성제의 도입에 있어 전략적 역할을 수행함에 따라 2025년 28.4%의 점유율을 차지했습니다. 탄탄한 시장 환경, 첨단 산업 인프라, 지속가능한 솔루션의 높은 보급률로 인해 이 지역을 주요 성장 거점으로 삼고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추정 및 예측 : 유형별, 2022-2035
제6장 시장 추정 및 예측 : 형태별, 2022-2035
제7장 시장 추정 및 예측 : 등급별, 2022-2035
제8장 시장 추정 및 예측 : 최종사용자별, 2022-2035
제9장 시장 추정 및 예측 : 지역별, 2022-2035
제10장 기업 개요
KSM 26.05.06The Global Industrial Rhamnolipid Market was valued at USD 467.8 million in 2025 and is estimated to grow at a CAGR of 8.4% to reach USD 950.5 million by 2035.
Industrial rhamnolipids initially emerged as niche bio-based surfactants but have evolved into critical components across multiple industrial sectors. Their functional applications now extend to improving process efficiency, enhancing material compatibility, and ensuring operational reliability in areas such as energy production, industrial cleaning, agriculture, and environmental remediation. Industrial procurement is increasingly favoring inputs that deliver high performance while being renewable, minimally toxic, and environmentally sustainable. Advancements in biotechnology, fermentation control, strain optimization, and downstream processing have elevated rhamnolipid performance to meet industrial standards. The combination of formulation compatibility, biodegradability, and low environmental persistence has accelerated adoption, particularly in regions with stringent regulatory oversight and sustainability mandates, driving steady growth in both established and emerging markets.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $467.8 Million |
| Forecast Value | $950.5 Million |
| CAGR | 8.4% |
The mono-rhamnolipids segment held a 60.4% share and is expected to grow at a CAGR of 7.8% through 2035. Their widespread use is attributed to superior surface activity, solubility, and formulation compatibility. Industries leverage mono-rhamnolipids for applications including cleaning, oilfield chemistry, and environmental remediation due to their cost-effective performance in reducing interfacial tension. Di-rhamnolipids, though smaller in market size, are gaining traction for their superior emulsification properties, stability under extreme conditions, and long-term functional durability.
The liquid formulations segment held a 70.6% share in 2025 and is projected to grow at a CAGR of 8.1% from 2026 to 2035. Liquid rhamnolipids are preferred for large-scale industrial applications due to ease of handling, immediate solubility, and seamless integration into processes like oilfield operations, industrial cleaning, and environmental treatment. Their suitability for continuous processing, accurate dosing, and flexible formulation development reinforces their industrial popularity.
North America Industrial Rhamnolipid Market held a 28.4% share in 2025, driven by its strategic role in deploying bio-based surfactants across energy production, industrial cleaning, and environmental protection sectors. Favorable market conditions, advanced industrial infrastructure, and high adoption of sustainable solutions make the region a key growth hub.
Leading players in the Global Industrial Rhamnolipid Market include TensioGreen, GlycoSurf, Evonik Industries AG, Shaanxi Deguan Biotechnology Co. Ltd, Stepan Company, Holiferm Ltd, Biotensidon GmbH, CD BioGlyco, Zhejiang Silver Elephant Bioengineering Co. Ltd, Jeneil Biotech Inc, and AGAE Technologies LLC. Key strategies adopted by companies to strengthen their market presence include investing heavily in R&D to enhance rhamnolipid yield, purity, and functionality. Firms are optimizing fermentation and downstream processing for scalable, cost-effective production. Strategic partnerships with industrial users in energy, agriculture, and environmental remediation are expanding adoption. Companies are focusing on regulatory compliance, sustainable production practices, and eco-label certifications to differentiate their products. Expanding regional manufacturing capabilities and distribution networks ensures faster delivery and localized support. Additionally, marketing initiatives highlighting biodegradability, performance efficiency, and multi-sector versatility help build brand credibility and capture emerging market opportunities worldwide.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional
- 2.2.2 Type
- 2.2.3 Form
- 2.2.4 Grade
- 2.2.5 End-Use
- 2.3 TAM Analysis, 2026-2035
- 2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
- 2.5 Future Outlook and Strategic Recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising use in enhanced oil recovery (EOR) in the oil & gas industry
- 3.2.1.2 Growing applications in cosmetics and personal care industries
- 3.2.1.3 Rising demand for eco friendly & biodegradable surfactants
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High production cost
- 3.2.2.2 Limited availability of raw materials for rhamnolipid production
- 3.2.3 Market opportunities
- 3.2.3.1 Expansion in bioremediation & environmental applications
- 3.2.3.2 Pharmaceutical & drug delivery system development
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- 3.7 Price trends
- 3.7.1 By region
- 3.7.2 By type
- 3.8 Future market trends
- 3.9 Technology and Innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
- 3.10 Patent Landscape
- 3.11 Trade statistics (HS code)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
- 3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives
- 3.13 Carbon footprint consideration
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 LATAM
- 4.2.1.5 MEA
- 4.2.1 By region
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New Product Launches
- 4.6.4 Expansion Plans
Chapter 5 Market Estimates and Forecast, By Type, 2022-2035 (USD Million) (Kilo Tons)
- 5.1 Key trends
- 5.2 Mono-Rhamnolipids
- 5.3 Di-Rhamnolipids
Chapter 6 Market Estimates and Forecast, By Form, 2022-2035 (USD Million) (Kilo Tons)
- 6.1 Key trends
- 6.2 Liquid
- 6.2.1 Ready to Use
- 6.2.2 Concentrated
- 6.2.3 Aqueous Suspensions
- 6.3 Powder
- 6.3.1 Spray Dried
- 6.3.2 Freeze Dried
- 6.3.3 Bulk Industrial
Chapter 7 Market Estimates and Forecast, By Grade, 2022-2035 (USD Million) (Kilo Tons)
- 7.1 Key trends
- 7.2 Technical Grade (85-90%)
- 7.3 High Purity Grade (90-95%)
- 7.4 Ultra-High Purity Grade (>95%)
Chapter 8 Market Estimates and Forecast, By End-User, 2022-2035 (USD Million) (Kilo Tons)
- 8.1 Key trends
- 8.2 Oil & Gas
- 8.3 Agriculture
- 8.4 Pharmaceuticals & Healthcare
- 8.5 Cosmetics & Personal Care
- 8.6 Others (Textiles, Household & Industrial Cleaners, etc)
Chapter 9 Market Estimates and Forecast, By Region, 2022-2035 (USD Million) (Kilo Tons)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Evonik Industries AG
- 10.2 Stepan Company
- 10.3 AGAE Technologies LLC
- 10.4 Jeneil Biotech Inc
- 10.5 Biotensidon GmbH
- 10.6 GlycoSurf
- 10.7 TensioGreen
- 10.8 Zhejiang Silver Elephant Bio-engineering Co. Ltd
- 10.9 Shaanxi Deguan Biotechnology Co. Ltd
- 10.10 Holiferm Ltd
- 10.11 CD BioGlyco
